Clinical trial

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Theresa Jacob, PhD, MPHCompletedPhase 4Started Dec 6, 202215 enrolledUnited StatesNCT05615948

Abstract

The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Maimonides Medical CenterPsychiatryAspirinAntipyreticsPeripheral Nervous System AgentsSensory System AgentsAnesthetics, DissociativeExcitatory Amino Acid AntagonistsExcitatory Amino Acid AgentsCyclooxygenase InhibitorsOral Medications for depressionTreatment Resistant DepressionMajor Depressive DisorderAnalgesiaPeripheral Nervous System Agents

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025